Clinical trials
Phase 2 Fibrosis trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genfit | 1 |
| Gilead Sciences | 1 |
| Hoffmann-La Roche | 1 |
| Intercept Pharmaceuticals | 1 |
| Leiden University Medical Center | 1 |
| Mediar Therapeutics | 1 |
| Ocera Therapeutics, Inc. | 1 |
| Pulmovant, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 8 |
| Cardiovascular Diseases | 1 |
| Hepatic Encephalopathy | 1 |
| Hepatitis C | 1 |
| Hyperammonemia | 1 |
| Hypertension, Pulmonary | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Liver Cirrhosis, Biliary | 1 |
| Liver Diseases | 1 |
| Lung Diseases | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.